Examining the impact of biosimilar-to-biosimilar transition on effectiveness and safety
Expert Opin Biol Ther
.
2024 Feb 28:1-4.
doi: 10.1080/14712598.2024.2324123.
Online ahead of print.
Authors
Anan S Jarab
1
2
3
,
Shrouq R Abu Heshmeh
3
,
Ahmad Z Al Meslamani
1
2
Affiliations
1
College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.
2
AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates.
3
Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
PMID:
38404241
DOI:
10.1080/14712598.2024.2324123
No abstract available
Keywords:
Biosimilars; cross-switching; efficacy; safety.
Publication types
Editorial